What are the features of Xanthogranulomatous Pyelonephritis (XGPN) on Contrast-Enhanced Computed Tomography (CECT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CECT Features of Xanthogranulomatous Pyelonephritis (XGPN)

XGPN on CECT characteristically demonstrates multiple low-density fluid-filled cavities within an enlarged kidney with perinephric extension, typically associated with an obstructing renal calculus (most commonly staghorn) and hydronephrosis. 1

Primary Parenchymal Features

Renal enlargement is the most consistent finding, present in virtually all cases of XGPN on CECT. 2

Multiple dilated calyces with abnormal parenchyma appear in approximately 82% of cases, creating a characteristic multiloculated appearance. 2

Low-density fluid-filled areas within the renal parenchyma represent the hallmark CT feature, corresponding to dilated calyces filled with purulent material and lipid-laden macrophages. 1

Focal fat deposits within the inflamed renal parenchyma are identifiable in approximately 27% of cases, appearing as areas of negative attenuation values. 2

Associated Obstructive Features

Renal or upper ureteric calculus causing obstruction is present in 55-90% of cases, with staghorn calculi being particularly common. 3, 2

Hydronephrosis is demonstrable in all cases with solid tumors and represents a near-universal finding. 4

Non-functioning kidney on urography is one of the commonest findings when excretory studies are performed. 1

Extrarenal Extension Patterns

Perinephric extension occurs in 91-100% of cases and should be considered one of the most typical CT features of XGPN. 1, 2

Perinephric fat stranding and thickening of Gerota's fascia are present in all solid tumor cases. 4

Perinephric or psoas abscess develops in approximately 14-18% of cases. 3, 2

Extensive retroperitoneal inflammation extends beyond the perinephric space in approximately 27% of cases. 2

Diffuse vs. Focal Forms

Diffuse XGPN (88% of cases) involves the entire kidney with global enlargement and multiple cavities throughout. 3

Focal XGPN (12% of cases) presents as a localized mass, often mimicking renal cell carcinoma, and may be bifocal in rare instances (8.3%). 4, 3

Critical Diagnostic Pitfalls

The "great imitator" designation reflects XGPN's ability to mimic renal malignancy, particularly in focal forms where preoperative distinction from renal cancer is extremely difficult. 4

Cystic masses occur in 25% of cases, further complicating differentiation from cystic renal neoplasms. 4

Preoperative misdiagnosis is common, with pyonephrosis suspected in 50% of cases and neoplasia suspected in approximately 10% of cases. 3

Key Distinguishing Features

The combination of multiple low-density cavities, perinephric extension, obstructing calculus, and hydronephrosis should strongly suggest XGPN rather than malignancy. 1

Contrast-enhanced CT is the imaging modality of choice for diagnosing XGPN preoperatively, superior to ultrasound or unenhanced imaging. 1

The average tumor size in pseudotumoral presentations is approximately 6.6 cm. 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.